We are one of Australia’s flagship biomedical research institutes
Established in February 2000, through investment from Griffith University and the Queensland State Government, the Institute for Glycomics is one of Australia’s flagship multidisciplinary biomedical research institutes. We strive to be world leaders in the discovery and development of next generation drugs, vaccines and diagnostics for diseases of global impact.
The Institute boasts state-of-the-art facilities combined with some of the world’s most outstanding researchers with a focus on 'Glycoscience', a constantly expanding field that explores the structural and functional properties of complex carbohydrates (or sugars). Glycoscience research is conducted worldwide in projects that cut across multiple disciplines, applying new approaches to treatment and prevention of diseases. The Institute’s research primarily targets prevention and cures for cancers and infectious diseases, with a focus on translational research which will inevitably have a positive impact on human health globally.
This rich research environment also provides exceptional postgraduate education programs for the nation’s future scientists. The Institute also engages with industry, other premier research institutes, philanthropic organisations and governments from across the globe to build human capital to provide healthcare solutions to address some of the world’s most intractable diseases.
200+ research and support members
$10,000,000+ external research income p.a.
100+ peer reviewed publications p.a.
Dr Chris Davis
Having more than thirteen years management experience in innovation and commercialisation, working at the academic/industry interface, Chris' role is to lead a group of professionals dedicated to the strategic and operational development of the Institute. As General Manager, his primary focus is on translation and commercialisation of our scientific discoveries for social and economic benefit, locally and globally.
Chris has held a number of board positions. He is currently Deputy Chair of the Ausbiotech Ltd Qld Committee.
We are located within the Gold Coast Health and Knowledge Precinct
The Institute for Glycomics is based at the heart of Griffith University’s Gold Coast campus, which falls within the 200-hectare Gold Coast Health and Knowledge Precinct (GCHKP). The Precinct is a unique global business location for high-tech industry development, research collaboration and jobs of the future.
Supported by $5 billion in infrastructure, including the world-class Griffith University and two major hospitals, the Precinct is transforming Australia’s leading lifestyle city. With a combination of expertise, infrastructure, land and lifestyle unique in Australia, nine hectares of greenfield land are available for health and innovation investment, serviced by the Gold Coast light rail and with easy transport access.
The Institute for Glycomics has a strong global investment attraction strategy for leading biotechnology companies, leveraging clinical research and trial opportunities with the co-located Gold Coast University Hospital and Gold Coast Private Hospital, as well as Menzies Health Institute Queensland.
The GCHKP, which currently boasts almost 10,000 staff and more than 18,000 students, is set to employ over 26,000 people—11% of current Gold Coast jobs—generating gross value of $2.9 billion for the city’s economy. It’s also a vibrant mixed-use community in which to live, work, study and play. Set to be home to 2,500 residents the GCHKP boasts parkland and green spaces, street-level retail and dining, co-working and innovation spaces, entertainment facilities and a boutique hotel.